Between January and November 2019, Russia imported 118 bln RUB worth of APIs (customs clearance prices, VAT included), which is in monetary terms (rubles) 35.6% higher than that of the same period in 2018. The dynamics in physical terms (tons) are +12.9%, with 12 thousand tons. Price rises are obviously the main growth factor here.

Between January and November 2019, Russia imported 33.1 bln RUB worth of veterinary drugs (customs clearance prices, VAT included), which is surprisingly higher than the import of feed supplements (32.5 bln RUB). The reason lies both in the sudden growth of veterinary drug imports (+41.7% in rubles) and the significant drop in feed supplement imports (-7.7%). The import of veterinary APIs still has the highest dynamics among the veterinary product imports (+66.3% and 2.9 bln RUB).

Between January and November 2019, Russia imported 703.9 bln RUB worth of ready-made pharmaceutical drugs (customs clearance prices, VAT included), which is in monetary terms (rubles) 47.7% higher than that of the same period in 2018, and 116.3 bln RUB worth of in-bulk drugs, with the dynamics in monetary terms of +18.9%.

Between January and November 2019, Russia manufactured 383.9 bln RUB worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 25.8% higher than the production volume in 2018. In physical terms, the production volume is 4.1 bln units, or 67.2 bln minimum dosage units (MDU). The dynamics in physical terms are +6.5% in units and +5.3% in MDU.

The vast majority of doctors (92%) consider the official statistics of the Ministry of Health and Rosstat on average salaries not reliable, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Around 37% of the respondents consider the official statistics to be completely unreliable, believing that the figures provided by Ministry of Health are “several times” higher than the real ones.

Between January and September 2019, Russia exported 32.5 bln RUB worth of pharmaceutical drugs (customs duties included), which is in monetary terms (rubles) 22.4% higher than that of the same in 2018. The two-digit growth rates have been registered since 2018 (the dynamics in 2018 were +16.1%). The dynamics in physical terms (units) are +6.7%, with 653 mln units.

35% of doctors believe that the main cause of medical errors are “excessive workloads”, followed by “failures of the healthcare system”, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. However, excessive workloads are also a direct result of the improper organization of the healthcare system.

The Russia market of veterinary products consists of two main segments: households’ purchases and agricultural complexes and farms’ purchases. The volume of households’ purchases amounted to 18.1 bln RUB (retail prices, VAT included) in October 2019. Pet medicines account for 92% of the volume in monetary terms, while livestock medicines – for around 8%.

Between January and September 2019, Russia imported 532.3 thousand units, 13.1 bln RUB worth of pharmaceutical drugs for clinical trials (CT) (customs clearance prices, VAT included). The dynamics in physical terms (units) are only +0.4%. The dynamics in monetary terms (rubles) are much higher, +9.8%. The importers were most active in Q3 2019.

Between January and October 2019, Russia manufactured 341.3 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 23.6% higher than that of the same period in 2018. In physical terms, the dynamics are only +0.8% in units and +0.4% in minimum dosage units (MDU). The total production volume is 3.5 bln units and around 57.9 bln MDUs.